3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
181
Lymphoma
97
Lymphoma, Large B-Cell, Diffuse
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Sarcoma
69
Hodgkin Disease
54
Lymphoma, Non-Hodgkin
41
Triple Negative Breast Neoplasms
37
Burkitt Lymphoma
36
Lymphoma, Mantle-Cell
32
Leukemia
32
Lymphoma, Follicular
30
Multiple Myeloma
28
Carcinoma, Hepatocellular
28
Neoplasm Metastasis
23
Ovarian Neoplasms
21
Neoplasms
21
Lymphoma, Large-Cell, Anaplastic
18
Osteosarcoma
17
Lymphoma, B-Cell
17
Prostatic Neoplasms
16
Neuroblastoma
15
Lymphoma, T-Cell, Peripheral
15
Urinary Bladder Neoplasms
14
Recurrence
13
Lymphoma, Large-Cell, Immunoblastic
13
Inflammatory Breast Neoplasms
13
Immunoblastic Lymphadenopathy
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Stomach Neoplasms
10
Interventions
fludarabine
2
Paclitaxel
2
Nivolumab
2
Bevacizumab
2
rucaparib
1
liposomal doxorubicin
1
dostarlimab
1
Sunitinib
1
Stem Cell Transplantation
1
Sirolimus
1
Radiotherapy
1
Melphalan
1
Ipilimumab
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Doxorubicin
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Busulfan
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma, Clear Cell
×
Doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled